In PD patients, Nurr1 immunoreactive SN neurons are reduced by 65% and Nurr1 mRNA by 61% in peripheral blood mononuclear cells (PBMCs) compared to aged-matched healthy controls (Chu et al., 2006; Li et al., 2018). Here, NR4A2 is linked to Parkinson disease.